Clinical Trial Update: Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating IL13Ralpha2-CAR T cells for treating leptomeningeal metastasis, glioblastoma, ependymoma, and medulloblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma
• Glioblastoma
• Leptomeningeal Metastasis
• Medulloblastoma

Drugs mentioned

• IL13Ralpha2-CAR T Cells (IL13Ralpha2-targeted CAR T cells)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Ependymoma, Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING